PMC:7289100 / 44929-45276 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T524","span":{"begin":306,"end":322},"obj":"Disease"}],"attributes":[{"id":"A524","pred":"mondo_id","subj":"T524","obj":"http://purl.obolibrary.org/obo/MONDO_0012727"}],"text":"Moreover, in the clinical context exposed above, it is of note to report that Sars.CoV-2 shares 6 minimal immune determinants (KTVLK, TPEEH, RETMS, PFVVS, GLEAP, ICLLQ) with the Kawasaki antigen Inositol-trisphosphate 3-kinase C [122], thus highlighting as likely cross-reactions and consequent autoimmune Kawasaki disease in predisposed subjects."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T202","span":{"begin":187,"end":194},"obj":"Chemical"},{"id":"T203","span":{"begin":195,"end":203},"obj":"Chemical"}],"attributes":[{"id":"A202","pred":"chebi_id","subj":"T202","obj":"http://purl.obolibrary.org/obo/CHEBI_59132"},{"id":"A203","pred":"chebi_id","subj":"T203","obj":"http://purl.obolibrary.org/obo/CHEBI_17268"}],"text":"Moreover, in the clinical context exposed above, it is of note to report that Sars.CoV-2 shares 6 minimal immune determinants (KTVLK, TPEEH, RETMS, PFVVS, GLEAP, ICLLQ) with the Kawasaki antigen Inositol-trisphosphate 3-kinase C [122], thus highlighting as likely cross-reactions and consequent autoimmune Kawasaki disease in predisposed subjects."}

{"project":"LitCovid-sentences","denotations":[{"id":"T277","span":{"begin":0,"end":347},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Moreover, in the clinical context exposed above, it is of note to report that Sars.CoV-2 shares 6 minimal immune determinants (KTVLK, TPEEH, RETMS, PFVVS, GLEAP, ICLLQ) with the Kawasaki antigen Inositol-trisphosphate 3-kinase C [122], thus highlighting as likely cross-reactions and consequent autoimmune Kawasaki disease in predisposed subjects."}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T614","span":{"begin":78,"end":82},"obj":"PR:000014459;SP_7"},{"id":"T615","span":{"begin":82,"end":88},"obj":"SP_7"},{"id":"T616","span":{"begin":106,"end":112},"obj":"UBERON:0002405"},{"id":"T617","span":{"begin":187,"end":194},"obj":"CHEBI:59132;CHEBI:59132"},{"id":"T618","span":{"begin":295,"end":305},"obj":"UBERON:0002405"},{"id":"T13328","span":{"begin":78,"end":82},"obj":"PR:000014459;SP_7"},{"id":"T46349","span":{"begin":82,"end":88},"obj":"SP_7"},{"id":"T61868","span":{"begin":106,"end":112},"obj":"UBERON:0002405"},{"id":"T34935","span":{"begin":187,"end":194},"obj":"CHEBI:59132;CHEBI:59132"},{"id":"T47591","span":{"begin":295,"end":305},"obj":"UBERON:0002405"}],"text":"Moreover, in the clinical context exposed above, it is of note to report that Sars.CoV-2 shares 6 minimal immune determinants (KTVLK, TPEEH, RETMS, PFVVS, GLEAP, ICLLQ) with the Kawasaki antigen Inositol-trisphosphate 3-kinase C [122], thus highlighting as likely cross-reactions and consequent autoimmune Kawasaki disease in predisposed subjects."}

{"project":"LitCovid-PubTator","denotations":[{"id":"1515","span":{"begin":195,"end":228},"obj":"Gene"},{"id":"1522","span":{"begin":78,"end":88},"obj":"Species"},{"id":"1527","span":{"begin":295,"end":322},"obj":"Disease"}],"attributes":[{"id":"A1515","pred":"tao:has_database_id","subj":"1515","obj":"Gene:80271"},{"id":"A1522","pred":"tao:has_database_id","subj":"1522","obj":"Tax:2697049"},{"id":"A1527","pred":"tao:has_database_id","subj":"1527","obj":"MESH:D009080"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Moreover, in the clinical context exposed above, it is of note to report that Sars.CoV-2 shares 6 minimal immune determinants (KTVLK, TPEEH, RETMS, PFVVS, GLEAP, ICLLQ) with the Kawasaki antigen Inositol-trisphosphate 3-kinase C [122], thus highlighting as likely cross-reactions and consequent autoimmune Kawasaki disease in predisposed subjects."}

{"project":"2_test","denotations":[{"id":"32535093-18084290-4828892","span":{"begin":230,"end":233},"obj":"18084290"}],"text":"Moreover, in the clinical context exposed above, it is of note to report that Sars.CoV-2 shares 6 minimal immune determinants (KTVLK, TPEEH, RETMS, PFVVS, GLEAP, ICLLQ) with the Kawasaki antigen Inositol-trisphosphate 3-kinase C [122], thus highlighting as likely cross-reactions and consequent autoimmune Kawasaki disease in predisposed subjects."}